Glenmark Pharmaceuticals
Glenmark in $325-million drug deal with Sanofi-Aventis
03 May 2010
Under the terms of the agreement, Glenmark will receive an upfront payment as well as development, regulatory and commercial milestone payments, that could reach a total of $325 million
Glenmark launches two new generics in UK
07 Apr 2010
Glenmark gets nod to market skin cream in US
16 Nov 2009
Glenmark, Forest drug trial for COPD fails
19 Aug 2009
Glenmark to withdraw painkiller from US market
02 Apr 2009
